Effect of a new V1 antagonist (OPC-21268) on vascular action of vasopressin in cultured rat vascular smooth muscle cells
- 31 July 1991
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 178 (2) , 707-712
- https://doi.org/10.1016/0006-291x(91)90165-4
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- OPC-21268, an Orally Effective, Nonpeptide Vasopressin V1 Receptor AntagonistScience, 1991
- Effect of vasopressin on Na+ kinetics in cultured rat vascular smooth muscle cellsBiochemical and Biophysical Research Communications, 1990
- Effect of inhibition of Na+/K(+)-adenosine triphosphatase on vascular action of vasopressin.Journal of Clinical Investigation, 1990
- Arginine Vasopressin Increases Cellular Free Calcium Concentration and Adenosine 3',5'-Monophosphate Production in Rat Renal Papillary Collecting Tubule Cells in Culture*Endocrinology, 1988
- [1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine]arginine-vasopressin and [1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid)]arginine-vasopressin, two highly potent antagonists of the vasopressor response to arginine-vasopressinJournal of Medicinal Chemistry, 1980